BioCryst Pharmaceuticals, Inc.
BioCryst is a small-cap specialty pharma focused on rare diseases with minimal direct government dependence but subject to standard FDA/Medicare regulatory oversight.
BusinessWhat BCRX does
BioCryst Pharmaceuticals develops and commercializes therapies for rare genetic diseases, including hereditary angioedema (HAE) and other conditions. Revenue is primarily driven by specialty pharmaceutical sales to hospitals, specialty pharmacies, and patient assistance programs, with limited Medicare/Medicaid exposure relative to large-cap pharma.
12 months past · 3 months futureBCRX activity timeline
Lifetime Government AwardsBCRX federal contracts
BCRX doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding BCRX
Politicians Trading BCRXMembers of Congress with recent BCRX positions
Congressional TradesWho in Congress is trading BCRX
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere BCRX sits in Washington
BioCryst has minimal lobbying footprint, no named legislative winners/losers, and rare-disease focus insulates it from broad pharma pricing debates. Stock moves primarily on clinical/commercial data, not policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA approval delays
- Medicare coverage restrictions
- drug pricing pressure
Regulatory opportunities
- Orphan drug exclusivity extension
- Rare disease tax credits
- Expedited FDA pathways
Live signals + predictions for BCRX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BCRX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord